Drug offers hope in treating ocular melanoma

Video

Richard Carvajal, MD, associate professor at Columbia University Medical Center, discusses one drug potential to treat ocular melanoma at ARVO 2018 in Honolulu.

The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or UBM Medica.

Richard Carvajal, MD, associate professor at Columbia University Medical Center, discusses one drug potential to treat ocular melanoma at ARVO 2018 in Honolulu.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Dr. Julie Rodman discusses retina, imaging, and posterior segment in SECO presentations
Dr. Julie Rodman previews her SECO presentations
Related Content
Visual field test and OCT images on table Image credit: AdobeStock/izzuan

Taking your OCT outside of the posterior pole

Jim Williamson, OD, FAAO, FORS
June 12th 2025
Article
Optometry Times You and Eye

You and Eye: What optometrists need to know about low vision

Miriam Korik, OD;Emily Kaiser Maharjan, Assistant Managing Editor
March 13th 2024
Podcast
Doctor pushing button on AI graphic Image credit: AdobeStock/Toowongsa

AI therapy planning support assistant launched by deepeye Medical receives CE mark

Jordana Joy, Associate Editor
May 28th 2025
Article
Advances in treatment for geographic atrophy

Advances in treatment for geographic atrophy

David S. Boyer, MD;Tina Mac Donald, OD, CDCES, FAAO;Leo P. Semes, OD, FAAO
October 11th 2023
Podcast
FDA expands Susvimo’s indications to include diabetic retinopathy

FDA expands Susvimo’s indications to include diabetic retinopathy

Martin David Harp, Editor, Ophthalmology Times;Emily Kaiser Maharjan, Assistant Managing Editor
May 22nd 2025
Article
Doctor administering glucose level test Image credit: AdobeStock/interstid

Hypoglycemia may promote a breakdown of the blood-retinal barrier, study finds

Kassi Filkins, Editor
May 22nd 2025
Article
© 2025 MJH Life Sciences

All rights reserved.